Page last updated: 2024-08-23

bezafibrate and Stroke

bezafibrate has been researched along with Stroke in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hao, Z; Liu, B; Liu, M; Tao, W; Wang, D1
Briel, M; Ferreira-González, I; Jakob, T; Nordmann, AJ; Schandelmaier, S1
Adler, Y; Behar, S; Boyko, V; Goldbourt, U; Haim, M; Matetzky, S; Mekori, YA; Reshef, T; Tanne, D1
Cook, C; Cooper, J; Meade, T; Zuhrie, R1
Hata, T; Ishikawa, K; Kitagawa, Y; Ohta, T; Shinohara, Y; Tomiyasu, H; Yamamoto, M1
Mikhailidis, DP; Rizos, E1
Behar, S; Benderly, M; Boyko, V; Brunner, D; Goldbourt, U; Graff, E; Mandelzweig, L; Reicher-Reiss, H; Shotan, A; Tanne, D1

Reviews

3 review(s) available for bezafibrate and Stroke

ArticleYear
Fibrates for secondary prevention of cardiovascular disease and stroke.
    The Cochrane database of systematic reviews, 2015, Oct-25, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Clofibrate; Coronary Disease; Female; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypertriglyceridemia; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke

2015
Fibrates for primary prevention of cardiovascular disease events.
    The Cochrane database of systematic reviews, 2016, 11-16, Volume: 11

    Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Myocardial Infarction; Primary Prevention; Simvastatin; Stroke

2016
Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
    Cardiovascular research, 2001, Volume: 52, Issue:2

    Topics: Adult; Bezafibrate; Biomarkers; Cholesterol; Coronary Disease; Female; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Triglycerides

2001

Trials

3 trial(s) available for bezafibrate and Stroke

ArticleYear
Bezafibrate in men with lower extremity arterial disease: randomised controlled trial.
    BMJ (Clinical research ed.), 2002, Nov-16, Volume: 325, Issue:7373

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arteries; Bezafibrate; Coronary Disease; Double-Blind Method; Humans; Leg; Male; Middle Aged; Peripheral Vascular Diseases; Stroke; Treatment Outcome

2002
Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia.
    The Tokai journal of experimental and clinical medicine, 2005, Volume: 30, Issue:1

    Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Hyperlipidemias; Intercellular Adhesion Molecule-1; Male; Pravastatin; Solubility; Stroke; Triglycerides

2005
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
    The American journal of medicine, 2001, Oct-15, Volume: 111, Issue:6

    Topics: Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk; Severity of Illness Index; Stroke; Triglycerides

2001

Other Studies

1 other study(ies) available for bezafibrate and Stroke

ArticleYear
Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.
    Stroke, 2002, Volume: 33, Issue:9

    Topics: Bezafibrate; Biomarkers; Brain Ischemia; Case-Control Studies; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Israel; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke

2002